Tela Bio Inc (TELA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,862 | -33,276 | -24,657 | -16,391 | -8,136 |
| Depreciation Amortization | 154 | 535 | 398 | 271 | 140 |
| Accounts receivable | -85 | -1,553 | -896 | -862 | -112 |
| Accounts payable and accrued liabilities | 3,274 | 1,597 | 1,586 | 570 | 312 |
| Other Working Capital | -801 | -2,018 | 88 | -518 | -1,439 |
| Other Operating Activity | -2,110 | 4,283 | 2,637 | 2,716 | 650 |
| Operating Cash Flow | $-10,430 | $-30,432 | $-20,844 | $-14,214 | $-8,585 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -336 | -627 | -338 | -47 | -22 |
| Investing Cash Flow | $-336 | $-627 | $-338 | $-47 | $-22 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 7 | 585 | 411 | 152 | 36 |
| Other Financing Activity | -153 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $-146 | $585 | $411 | $152 | $36 |
| Exchange Rate Effect | -3 | 11 | 13 | 7 | 6 |
| Beginning Cash Position | 43,931 | 74,394 | 74,394 | 74,394 | 74,394 |
| End Cash Position | 33,016 | 43,931 | 53,636 | 60,292 | 65,829 |
| Net Cash Flow | $-10,915 | $-30,463 | $-20,758 | $-14,102 | $-8,565 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,430 | -30,432 | -20,844 | -14,214 | -8,585 |
| Capital Expenditure | -336 | -627 | -338 | -47 | -22 |
| Free Cash Flow | -10,766 | -31,059 | -21,182 | -14,261 | -8,607 |